Mira Pharmaceuticals Inc (MIRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 1,317 | 1,546 | 1,805 | 2,438 | 2,082 |
| Operating Income | -1,317 | -1,546 | -1,805 | -2,438 | -2,082 |
| Interest Expense | 0 | -9 | -21 | -76 | 0 |
| Other Income | 179 | 0 | 0 | -38 | 38 |
| Pre-tax Income | -1,138 | -1,538 | -1,784 | -2,400 | -2,044 |
| Net Income Continuous | -1,138 | -1,538 | -1,784 | -2,400 | -2,044 |
| Net Income | $-1,138 | $-1,538 | $-1,784 | $-2,400 | $-2,044 |
| EPS Basic Total Ops | -1.18 | -0.09 | -0.11 | -0.11 | -0.14 |
| EPS Basic Continuous Ops | -0.06 | -0.09 | -0.11 | -0.14 | -0.14 |
| EPS Diluted Total Ops | -1.18 | -0.09 | -0.11 | -0.11 | -0.14 |
| EPS Diluted Continuous Ops | -0.06 | -0.09 | -0.11 | -0.14 | -0.14 |
| EPS Diluted Before Non-Recurring Items | -1.18 | -0.09 | -0.11 | -0.15 | -0.14 |
| EBITDA(a) | $-1,317 | $-1,546 | $-1,805 | $-2,438 | $-2,082 |